TY - JOUR
T1 - Development and Piloting of Implementation Strategies to Support Delivery of a Clinical Intervention for Postpartum Hemorrhage in Four sub-Saharan Africa Countries
AU - Forbes, Gillian
AU - Akter, Shahinoor
AU - Miller, Suellen
AU - Galadanci, Hadiza
AU - Qureshi, Zahida
AU - Alwy Al-Beity, Fadhlun
AU - Hofmeyr, G. Justus
AU - Moran, Neil
AU - Fawcus, Sue
AU - Singata-Madliki, Mandisa
AU - Wakili, Aminu Ado
AU - Amole, Taiwo Gboluwaga
AU - Musa, Baba Maiyaki
AU - Dankishiya, Faisal
AU - Atterwahmie, Adamu Abdullahi
AU - Muhammad, Abubakar Shehu
AU - Ekweani, John
AU - Nzeribe, Emily
AU - Osoti, Alfred
AU - Gwako, George
AU - Okore, Jenipher
AU - Kikula, Amani
AU - Metta, Emmy
AU - Mwampashi, Ard
AU - Evans, Cherrie
AU - Mammoliti, Kristie Marie
AU - Devall, Adam
AU - Coomarasamy, Arri
AU - Gallos, Ioannis
AU - Oladapo, Olufemi T.
AU - Bohren, Meghan A.
AU - Lorencatto, Fabiana
N1 - Publisher Copyright:
© Forbes et al.
PY - 2024/10/29
Y1 - 2024/10/29
N2 - Introduction: Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality. A new clinical intervention (E-MOTIVE) holds the potential to improve early PPH detection and management. We aimed to develop and pilot implementation strategies to support uptake of this intervention in Kenya, Nigeria, South Africa, and Tanzania. Methods: Implementation strategy development: We triangulated findings from qualitative interviews, surveys and a qualitative evidence synthesis to identify current PPH care practices and influences on future intervention implementation. We mapped influences using implementation science frameworks to identify candidate implementation strategies before presenting these at stakeholder consultation and design workshops to discuss feasibility, acceptability, and local adaptations. Piloting: The intervention and implementation strategies were piloted in 12 health facilities (3 per country) over 3 months. Interviews (n=58), case report forms (n=1,269), and direct observations (18 vaginal births, 7 PPHs) were used to assess feasibility, acceptability, and fidelity. Results: Implementation strategy development: Key influences included shortages of drugs, supplies, and staff, limited in-service training, and perceived benefits of the intervention (e.g., more accurate PPH detection and reduced PPH mortality). Proposed implementation strategies included a PPH trolley, on-site simulation-based training, champions, and audit and feedback. Country-specific adaptations included merging the E-MOTIVE intervention with national maternal health trainings, adapting local PPH protocols, and PPH trollies depending on staff needs. Piloting: Intervention and implementation strategy fidelity differed within and across countries. Calibrated drapes resulted in earlier and more accurate PPH detection but were not consistently used at the start. Implementation strategies were feasible to deliver; however, some instances of limited use were observed (e.g., PPH trolley and skills practice after training). Conclusion: Systematic intervention development, piloting, and process evaluation helped identify initial challenges related to intervention fidelity, which were addressed ahead of a larger-scale effectiveness evaluation. This has helped maximize the internal validity of the trial.
AB - Introduction: Postpartum hemorrhage (PPH) remains the leading cause of maternal mortality. A new clinical intervention (E-MOTIVE) holds the potential to improve early PPH detection and management. We aimed to develop and pilot implementation strategies to support uptake of this intervention in Kenya, Nigeria, South Africa, and Tanzania. Methods: Implementation strategy development: We triangulated findings from qualitative interviews, surveys and a qualitative evidence synthesis to identify current PPH care practices and influences on future intervention implementation. We mapped influences using implementation science frameworks to identify candidate implementation strategies before presenting these at stakeholder consultation and design workshops to discuss feasibility, acceptability, and local adaptations. Piloting: The intervention and implementation strategies were piloted in 12 health facilities (3 per country) over 3 months. Interviews (n=58), case report forms (n=1,269), and direct observations (18 vaginal births, 7 PPHs) were used to assess feasibility, acceptability, and fidelity. Results: Implementation strategy development: Key influences included shortages of drugs, supplies, and staff, limited in-service training, and perceived benefits of the intervention (e.g., more accurate PPH detection and reduced PPH mortality). Proposed implementation strategies included a PPH trolley, on-site simulation-based training, champions, and audit and feedback. Country-specific adaptations included merging the E-MOTIVE intervention with national maternal health trainings, adapting local PPH protocols, and PPH trollies depending on staff needs. Piloting: Intervention and implementation strategy fidelity differed within and across countries. Calibrated drapes resulted in earlier and more accurate PPH detection but were not consistently used at the start. Implementation strategies were feasible to deliver; however, some instances of limited use were observed (e.g., PPH trolley and skills practice after training). Conclusion: Systematic intervention development, piloting, and process evaluation helped identify initial challenges related to intervention fidelity, which were addressed ahead of a larger-scale effectiveness evaluation. This has helped maximize the internal validity of the trial.
UR - http://www.scopus.com/inward/record.url?scp=85208203868&partnerID=8YFLogxK
U2 - 10.9745/GHSP-D-23-00387
DO - 10.9745/GHSP-D-23-00387
M3 - Article
C2 - 39261009
AN - SCOPUS:85208203868
VL - 12
JO - Global Health Science and Practice
JF - Global Health Science and Practice
IS - 5
M1 - e2300387
ER -